首页> 外文期刊>Current Microbiology >Oral Administration of Clostridium butyricum for Modulating Gastrointestinal Microflora in Mice
【24h】

Oral Administration of Clostridium butyricum for Modulating Gastrointestinal Microflora in Mice

机译:丁酸梭菌口服给药调节小鼠胃肠道菌群

获取原文
获取原文并翻译 | 示例
           

摘要

This study aimed to evaluate the safety of Clostridium butyricum and to investigate the effect of C. butyricum on mice ecosystem in the intestinal tract by way of examining the population of different microorganisms isolated from caecal contents. We firstly evaluated the safety of C. butyricum using acute toxicity test and Ames test. Then forty male BALB/c mice were divided into the following four treatment groups, each consisting of ten mice: normal group, low-dose group, medium-dose group and high-dose group. Caecal contents were removed aseptically, immediately placed into an anaerobic chamber, and dissolved in sterile pre-reduced PBS. The determination of Enterococcus spp., Enterobacter spp., Lactobacillus spp., Bifidobacterium spp. and Clostridium perfringens was analyzed by the spread plate method, cell morphologies and biochemical profiles. The results showed the oral maximum tolerated dose of C. butyricum was more than 10 g/kg body weight in mice and no mutagenicity judged by negative experimental results of Ames test. And in medium- and high-dose groups, the populations of Bifidobacterium spp. and Lactobacillus spp. increased in caecum, as well as the ratios of Bifidobacterium spp. and Lactobacillus spp. to Clostridium perfringens (P < 0.01) as compared with the normal group. This research showed the intake of C. butyricum significantly improved the ecosystem of the intestinal tract in BALB/c mice by increasing the amount of probiotics and reducing the populations of unwanted bacteria.
机译:本研究旨在评估酪酸梭菌的安全性,并通过检查从盲肠内容物中分离出的不同微生物的种群,来研究酪酸梭菌对肠道小鼠生态系统的影响。我们首先使用急性毒性试验和Ames试验评估丁酸梭菌的安全性。然后将四十只雄性BALB / c小鼠分为以下四个治疗组,每组由十只小鼠组成:正常组,低剂量组,中剂量组和高剂量组。无菌除去盲肠内容物,立即置于厌氧室中,并溶于无菌的预还原PBS中。肠球菌属,肠杆菌属,乳杆菌属,双歧杆菌属的测定。通过铺板法,细胞形态和生化特征分析产气荚膜梭菌。结果表明,丁酸梭菌在小鼠中的口服最大耐受剂量大于10 g / kg体重,并且通过Ames试验的阴性实验结果没有判断出致突变性。在中等和高剂量组中,双歧杆菌属。和乳杆菌属。盲肠以及双歧杆菌属的比例增加。和乳杆菌属。与正常人相比,产气荚膜梭状芽胞杆菌的抗药性(P <0.01)。这项研究表明,丁酸梭菌的摄入通过增加益生菌的数量和减少有害细菌的数量,大大改善了BALB / c小鼠肠道的生态系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号